- Joined
- Mar 17, 2003
- Messages
- 2,962
- Reaction score
- 79
Saw this in the Journal this morning.
http://online.wsj.com/article/SB10001424127887324021104578553793173806004.html?mod=hp_jrmodule
Pretty much across the board the experts think we should be paid for results and not for amount of work (so called value over volume). One expert said that the orthopedic surgeon should be paid based on how the patient is performing and how satisified the patient is six months after the operation.
That seemed a little silly to me. If your toilet breaks, you call the plumber and pay him once he is done. You don't pay him after six months if you are still happy with the flush.
But in any case I see the point of value over volume when it comes to primary care docs and other heavy clinic based specialties. But how would pathologists be reimbursed in this new system? Let's say a patient gets BCR-ABL positive ALL. I do the bone marrow, order the anciallary studies, do the micro and then put it all together. If I am going to be reimbursed on outcomes, how is this patient going to have a good outcome? How can you measure the quality of life of someone who will be aggressively treated and almost certainly die in a year or so? Or reading GI biopsies, how does someone have a good outcome after having their tubular adenoma signed out?
My point is that in pathology we have no real control about what happens to our "patients".
Moreover in pathology shouldn't someone that does twice as much work get paid twice as much or at least more due to the value of his volume?
I propose that pathologists should continue to get fee for service but with decreased reimbursement if our cases don't have essential information to better treat the patient.
http://online.wsj.com/article/SB10001424127887324021104578553793173806004.html?mod=hp_jrmodule
Pretty much across the board the experts think we should be paid for results and not for amount of work (so called value over volume). One expert said that the orthopedic surgeon should be paid based on how the patient is performing and how satisified the patient is six months after the operation.
That seemed a little silly to me. If your toilet breaks, you call the plumber and pay him once he is done. You don't pay him after six months if you are still happy with the flush.
But in any case I see the point of value over volume when it comes to primary care docs and other heavy clinic based specialties. But how would pathologists be reimbursed in this new system? Let's say a patient gets BCR-ABL positive ALL. I do the bone marrow, order the anciallary studies, do the micro and then put it all together. If I am going to be reimbursed on outcomes, how is this patient going to have a good outcome? How can you measure the quality of life of someone who will be aggressively treated and almost certainly die in a year or so? Or reading GI biopsies, how does someone have a good outcome after having their tubular adenoma signed out?
My point is that in pathology we have no real control about what happens to our "patients".
Moreover in pathology shouldn't someone that does twice as much work get paid twice as much or at least more due to the value of his volume?
I propose that pathologists should continue to get fee for service but with decreased reimbursement if our cases don't have essential information to better treat the patient.